Regulus Therapeutics Inc. (RGLS), a company specializing in microRNA-targeted medicines, announced on Thursday the promotion of Rekha Garg to Chief Medical Officer, effective May 16. Previously, Garg held the position of Senior Vice President, Clinical Development and Regulatory at the company.